RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci
- 30 April 1993
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 16 (3), 223-226
- https://doi.org/10.1016/0732-8893(93)90113-l
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- In vitro antistaphylococcal activity and testing of RP 59500, a new streptogramin, by two methodsAntimicrobial Agents and Chemotherapy, 1992
- In-vitro and in-vivo synergic activity and fractional inhibitory concentration (FIC of the components of a semisynthetic streptogramin, RP 59500Journal of Antimicrobial Chemotherapy, 1992
- A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500Journal of Antimicrobial Chemotherapy, 1992
- Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP 59500 and related compoundsJournal of Antimicrobial Chemotherapy, 1992
- In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococciAntimicrobial Agents and Chemotherapy, 1991
- WORLD-WIDE ANTIBIOTIC RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUSThe Lancet, 1989
- In-vitro susceptibility of oral streptococci to pristinamycinJournal of Antimicrobial Chemotherapy, 1987